(NASDAQ: ANIK) Anika Therapeutics's forecast annual revenue growth rate of 6.16% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.85%.
Anika Therapeutics's revenue in 2025 is $105,552,000.On average, 2 Wall Street analysts forecast ANIK's revenue for 2025 to be $1,582,360,907, with the lowest ANIK revenue forecast at $1,579,994,572, and the highest ANIK revenue forecast at $1,584,727,242. On average, 2 Wall Street analysts forecast ANIK's revenue for 2026 to be $1,716,668,333, with the lowest ANIK revenue forecast at $1,679,380,633, and the highest ANIK revenue forecast at $1,753,956,033.
In 2027, ANIK is forecast to generate $1,813,616,353 in revenue, with the lowest revenue forecast at $1,813,616,353 and the highest revenue forecast at $1,813,616,353.